ANTITHROMBOTIC THERAPY AND PREVENTION OF THROMBOSIS, 9TH ED: ACCP GUIDELINES. The eighth iteration of the American. The New ACCP Guidelines on Antithrombotic Therapy Have Arrived The ninth edition has just been published as a supplement to the. The American College of Chest Physicians recently published “Antithrombotic Therapy and Prevention of Thrombosis: ACCP Evidence-Based Clinical Practice .
|Published (Last):||5 February 2018|
|PDF File Size:||4.60 Mb|
|ePub File Size:||1.82 Mb|
|Price:||Free* [*Free Regsitration Required]|
Antithrombotic Therapy for Atrial Fibrillation: This CHEST guideline series presents guixelines for the prevention, diagnosis, and treatment of thrombosis, addressing a comprehensive list of clinical conditions, including medical, surgery, orthopedic surgery, atrial fibrillation, stroke, cardiovascular disease, pregnancy, and neonates and children.
George, MD; Anna R. Acp develops slide sets to incorporate into educational presentations, for the purposes of disseminating and explaining guideline recommendations. Evidence-Based Management of Anticoagulant Therapy Recommendations for the general management of anticoagulant therapy.
ACCP – ACCP Report
These slides address initiation, maintenance, dosing, drug interactions, bleeding, and organization of care, offering guidance for many common anticoagulation-related management problems.
Prevention of Venous Thromboembolism in Nonsurgical Patients Recommendations regarding the decisions in prophylaxis in nonsurgical patients.
Recommendations incorporate perspectives in bleeding disorders, critical care, preventive medicine, methodology, and cost effectiveness. Prevention of Venous Thromboembolism in Nonorthopedic Surgical Patients Recommendations for optimal thromboprophylaxis in nonorthopedic surgical patients.
The slides address ef risks of venous thromboembolism and bleeding complications, as well as the values and preferences of individual patients. Prevention of Venous Thromboembolism in Orthopedic Surgery Patients Recommendations for the optimal strategies for thromboprophylaxis after major orthopedic surgery. Topics covered include pharmacologic and mechanical approaches to reduce patient-important outcomes, such as pulmonary embolism and symptomatic DVT. The Perioperative Management of Antithrombotic Therapy Recommendations to simplify patient management and minimize adverse clinical outcomes for perioperative antithrombotic management based on risk assessment for thromboembolism and bleeding.
Treatment and Prevention of Heparin-Induced Thrombocytopenia February Recommendations regarding heparin-induced thrombocytopenia and the primary efficacy outcome measures of interest, including new thrombosis, limb amputation, and major bleeding and death due to thrombosis or bleeding.
Ec Therapy in Atrial Fibrillation February Recommendations regarding atrial fibrillation based on net clinical benefit for patients at varying levels of stroke risk and in a number of common clinical scenarios.
Antithrombotic and Thrombolytic Therapy for Valves February Recommendations based on the optimal balance of thrombotic and hemorrhagic risk for antithrombotic therapy in valvular disease. Antithrombotic and Thrombolytic Therapy for Ischemic Stroke February Recommendations for the use of antithrombotic therapy in patients with stroke or transient ischemic attack.
The Primary and Secondary Prevention of Cardiovascular Disease February Recommendations focusing on long-term administration of antithrombotic drugs designed for primary and secondary prevention of cardiovascular disease, including two new antiplatelet therapies ticagrelor and prasugrel.
Antithrombotic Therapy in Peripheral Artery Disease February Recommendations regarding antithrombotic drug therapies for primary and secondary prevention of cardiovascular disease as well as for the relief of lower-extremity symptoms and critical antithrombotci in patients with peripheral arterial disease PAD.
Guidelines & Resources
The slide set highlights single antiplatelet therapy for primary and secondary prevention of cardiovascular events in most patients with asymptomatic PAD, symptomatic PAD, and asymptomatic carotid stenosis. Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy February Recommendations focusing on the management of giidelines thromboembolism and thrombophilia.
It discusses the use of antithrombotic agents during pregnancy and the associated challenges because of the potential for acxp fetal and maternal complications. Antithrombotic Therapy in Neonates and Children February Recommendations focusing on the monitoring to specific target ranges for both unfractionated and low-molecular-weight heparins in neonates and children. It acknowledges the ongoing need for dedicated clinical trials that demonstrate the differences in the pharmacokinetics, dose responses, and monitoring tests for anticoagulation therapy in children compared with adults.